Anaemia update from EHA 2013

Rituximab for b-cell lymphoma and EHA overview

Highlights from EHA 2013

Second line treatment of multiple myeloma with melphalan prednisone and lenalidomide

Challenges facing haematologists treating acute myeloid leukaemia

Cyclophosphamide lenalidomide and dexamethasone in newly diagnosed myeloma

Study shows pomalidomide prolongs survival in refractory myeloma patients

Paclitaxel dosing equally effective in preventing breast cancer progression

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer

Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

The problem of unnecessary treatment of prostate cancer